SWOG clinical trial number

SWOG-7719

Addition of DDP and Bleomycin to VBAP in Relapsing and Resistant Myeloma Patients

Closed

Abbreviated Title

Addition of DDP and Bleomycin to VBAP in Relapsing and Resistant Myeloma Patients

Activated

08/12/1977

Closed

10/17/1979

Publication Information Expand/Collapse

1984

Addition of Cisplatin and Bleomycin to Vincristine- Carmustine-Doxorubicin-Prednisone (VBAP) combination in the treatment of relapsing or resistant multiple myeloma: A Southwest Oncology Group study.

JD Bonnet;R Alexanian;SE Salmon;A Haut;DO Dixon Cancer Treat Rep 68: 481-485

1979

Cis-dichlorodiammineplatinum (II) in adult patients: Southwest Oncology Group studies.

R Stephens;C Coltman;A Rossof;M Samson;F Panettiere;M Al-Sarraf;D Alberts;J Bonnet Cancer Treat Rep 63(9-10):1609-1610

Cis-dichlorodiammineplatinum (II) in adult patients: Southwest Oncology Group studies.

R Stephens;C Coltman;A Rossof;M Samson;F Panettiere;M Al-Sarraf;D Alberts;J Bonnet Cancer Treat Rep 63(9-10):1609-1610

Cis-dichlorodiammineplatinum (II) in adult patients: Southwest Oncology Group studies.

R Stephens;C Coltman;A Rossof;M Samson;F Panettiere;M Al-Sarraf;D Alberts;J Bonnet Cancer Treat Rep 63(9-10):1609-1610

Cis-dichlorodiammineplatinum (II) in adult patients: Southwest Oncology Group studies.

R Stephens;C Coltman;A Rossof;M Samson;F Panettiere;M Al-Sarraf;D Alberts;J Bonnet Cancer Treat Rep 63(9-10):1609-1610

Cis-dichlorodiammineplatinum (II) in adult patients: Southwest Oncology Group studies.

R Stephens;C Coltman;A Rossof;M Samson;F Panettiere;M Al-Sarraf;D Alberts;J Bonnet Cancer Treat Rep 63(9-10):1609-1610